[Crataegus from the analytical viewpoint. Official contents of hawthorn drugs]
- PMID: 15700791
- DOI: 10.1002/pauz.200400100
[Crataegus from the analytical viewpoint. Official contents of hawthorn drugs]
Similar articles
-
[Qualitative control of crataegus extracts and preparations].Pharm Unserer Zeit. 2005;34(1):34-40. doi: 10.1002/pauz.200400102. Pharm Unserer Zeit. 2005. PMID: 15700793 Review. German. No abstract available.
-
Quantification of procyanidins in oral herbal medicinal products containing extracts of Crataegus species.Arzneimittelforschung. 2002;52(2):89-96. doi: 10.1055/s-0031-1299862. Arzneimittelforschung. 2002. PMID: 11878204
-
Phenolic compounds in hawthorn (Crataegus grayana) fruits and leaves and changes during fruit ripening.J Agric Food Chem. 2011 Oct 26;59(20):11141-9. doi: 10.1021/jf202465u. Epub 2011 Sep 26. J Agric Food Chem. 2011. PMID: 21905654
-
Hawthorn extracts inhibit LDL oxidation.Pharmazie. 2003 Aug;58(8):577-81. Pharmazie. 2003. PMID: 12967038
-
[The quality specification of grape seed extract].Zhongguo Zhong Yao Za Zhi. 2005 Sep;30(18):1406-8. Zhongguo Zhong Yao Za Zhi. 2005. PMID: 16381457 Review. Chinese.
Cited by
-
Hydroxycinnamic Acid Derivatives Obtained from a Commercial Crataegus Extract and from Authentic Crataegus spp.Sci Pharm. 2014 Aug 21;82(4):835-46. doi: 10.3797/scipharm.1404-02. Print 2014 Oct-Dec. Sci Pharm. 2014. PMID: 26171328 Free PMC article.
-
Crataegus Extract WS®1442 Stimulates Cardiomyogenesis and Angiogenesis From Stem Cells: A Possible New Pharmacology for Hawthorn?Front Pharmacol. 2019 Nov 27;10:1357. doi: 10.3389/fphar.2019.01357. eCollection 2019. Front Pharmacol. 2019. PMID: 31849643 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources